Free Trial
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel
NASDAQ:AGPU

Axe Compute Q2 2026 Earnings Results & Report

Axe Compute logo
$8.49 -0.11 (-1.31%)
As of 11:19 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Axe Compute reported Q2 2026 earnings on August 14, 2026. The company reported EPS of -$0.87, while revenue was $3.21 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
After Market Closes

Axe Compute EPS Results

Actual EPS
-$0.87
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Axe Compute Revenue Results

Actual Revenue
$3.21 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Axe Compute Q2 2026 Earnings FAQ

Axe Compute (NASDAQ:AGPU) reported earnings of -$0.87 per share for Q2 2026. The report was announced on Friday, August 14, 2026.

Axe Compute reported revenue of $3.21 million for Q2 2026.

Axe Compute Earnings Headlines

Axe Compute Signs Penguin Solutions as Strategic Partner to Accelerate Delivery of Next-Generation AI Infrastructure as Demand for Axe Compute Build Surges
October 14 at 8:30 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/14/3380714/37244/en/axe-compute-signs-penguin-solutions-as-strategic-partner-to-accelerate-delivery-of-next-generation-ai-infrastructure-as-demand-for-axe-compute-build-surges.html
Axe Compute Inc. to Ring Nasdaq Opening Bell Amid AI Infrastructure Growth and $3.45 Billion in Signed Contracts
October 9, 2026  |  quiverquant.comQ
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.tc pixel
October 15 at 1:00 AM  |  Porter & Company (Ad)
Axe Compute Extends Georgia AI Cluster Contract Term
October 5, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/axe-compute-extends-georgia-ai-cluster-contract-term?utm_source=marketbeat.com&utm_medium=referral
Axe Compute Takes Full Ownership of Georgia AI Cluster, Significantly Increasing the Contract's Expected Free Cash Flow and Gross Margin
October 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/05/3374546/37244/en/axe-compute-takes-full-ownership-of-georgia-ai-cluster-significantly-increasing-the-contract-s-expected-free-cash-flow-and-gross-margin.html
Axe Compute Receives More Than $184 Million in Customer Prepayments and Signs Over $266 Million in New AI Infrastructure Contracts Since Q2 Earnings Call
September 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/29/3370841/37244/en/axe-compute-receives-more-than-184-million-in-customer-prepayments-and-signs-over-266-million-in-new-ai-infrastructure-contracts-since-q2-earnings-call.html
See More Axe Compute Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Axe Compute? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Axe Compute and other key companies, straight to your email.

About Axe Compute

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using High-Throughput Self-Interaction Chromatography, a self-contained, automated system that conducts high-throughput, self-interaction chromatography screens using additives and excipients that are included in protein formulations for soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates staff exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. It also offers research and development services; and media that help cancer cells grow outside the patient's body and retain their DNA/RNA and proteomic signatures. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota.

View Axe Compute Profile
Earnings Tools